22 results
SC 13D
EX-2
Care Capital III LLC
23 Feb 18
Vaxart, Inc.
12:00am
8-K
EX-2.2
VXRT
Vaxart Inc
7 Feb 18
Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders
12:00am
425
EX-2.2
VXRT
Vaxart Inc
7 Feb 18
Business combination disclosure
12:00am
8-K
EX-2.1
VXRT
Vaxart Inc
7 Feb 18
Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders
12:00am
425
EX-2.1
VXRT
Vaxart Inc
7 Feb 18
Business combination disclosure
12:00am
8-K
EX-2.2
l1ic9ntq74wlgfek68y
30 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.3
ajy4c dlry837ba
30 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
vo993cpbjfjiulmgb
30 Oct 17
Entry into a Material Definitive Agreement
12:00am
425
EX-2.2
zz9ikn8l 66
30 Oct 17
Business combination disclosure
12:00am
425
EX-2.3
0nalg9
30 Oct 17
Business combination disclosure
12:00am
425
EX-2.1
y3qslcjozm21848h8y
30 Oct 17
Business combination disclosure
12:00am
SC 13D
EX-2
xe27kwj8
30 Jun 17
Aviragen Therapeutics, Inc.
12:00am
8-K
EX-2.1
s2qtp6f8ohe u6
18 Sep 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
zbud5ffe350i5
8 Aug 12
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-2.1
1wioodr0y09 vlmpg8u
23 Apr 12
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
ovm7a5goc p3t8
23 Apr 12
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-2.1
z14ef
24 Sep 01
Other events
12:00am
8-K/A
EX-2.2
eyz2e jq7ntpf
24 Sep 01
Other events
12:00am